Stem Cell Scientists Caution: Clinical Applications Remain Years Away

Photo: © Science VARIOUS STAGES: Human embryonic stem cell colonies, shown here in different states of development, sometimes include a core of undifferentiated cells surrounded by a margin of differentiated cells, such as the small colony at right in figure B. Gene therapy researchers call them the "ultimate target." Tissue transplant specialists refer to them as the "Holy Grail." Stem cells, perhaps because they play such a fundamental role in the developmental chain, tend to draw hyper

Written byPaul Smaglik
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Photo: © Science

VARIOUS STAGES: Human embryonic stem cell colonies, shown here in different states of development, sometimes include a core of undifferentiated cells surrounded by a margin of differentiated cells, such as the small colony at right in figure B.
Gene therapy researchers call them the "ultimate target." Tissue transplant specialists refer to them as the "Holy Grail." Stem cells, perhaps because they play such a fundamental role in the developmental chain, tend to draw hyperbole. But hyperbole resulting from two recently published reports on successful cultures of different lines of immortalized, pluripotent human stem cells in vitro, has made some of the researchers involved cringe. Unwelcome responses to the findings include media reports that would have scientists soon growing organs in petri dishes.

James A. Thomson, an associate research veterinarian at the University of Wisconsin's Regional Primate Research Center in Madison, led a group that derived stem cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies